Halyard Health (NYSE: HYH) reported Q3 EPS of $0.35, $0.11 worse than the analyst estimate of $0.46. Revenue for the quarter came in at $401.4 million versus the consensus estimate of $396.06 million.

GUIDANCE:

Halyard Health sees FY2017 EPS of $2.03-$2.13, versus the consensus of $1.95.

For earnings history and earnings-related data on Halyard Health (HYH) click here.